TABLE 1

Patient Characteristics and Chemotherapy Regimens

CharacteristicTotal (n = 92)
Median age, y (range)54 (19–78)
Sex: men/women60/32
Ann Arbor stage, no. (%)
 I−II11 (12)
 III−IV81 (88)
Standard IPI score, no. (%)
 Low risk (L)20 (22)
 Low-intermediate (LI)18 (19)
 High-intermediate (HI)30 (33)
 High (H)24 (26)
Chemotherapy regimen, no. (%)
 CHOP3 (3)
 R-CHOP27 (29)
 ACVBP/ACE42 (46)
 R-ACVBP20 (22)
  • IPI = International Prognostic Index; CHOP = cyclophosphamide, hydroxydaunomycin, oncovin (vincristine), prednisone; R = rituximab; ACVBP = adriamycin (doxorubicin), cyclophosphamide, vindesine, bleomycin, prednisone; ACE = adriamycin, cyclophosphamide, etoposide.